Sarah-Maria Fendt is a Principal Investigator at the VIB Center for Cancer Biology and Professor of Oncology at KU Leuven, Belgium. Her lab is specifically interested in understanding the role of metabolism in driving metastasis formation and in defining the principles of metabolic regulation that enable cancer cell plasticity and heterogeneity. Her team applies the powerful technologies of single cell and spatial multi-omics analysis in pre-clinical mouse models and patient samples to study the interplay between cancer cells and their metabolic environment during metastasis formation. The research in the lab is funded by multiple (inter)national grants and industry.  In 2020 she has been awarded with the EMBO Gold Medal and she is elected EMBO members since 2022. In 2023 she received the Francqui-Collen prize and the 51st Léopold Griffuel award. In 2024, Sarah-Maria Fendt was awarded with the AACR award for Outstanding Achievement in Basic Cancer Research.
Lab Website: https://fendtlab.sites.vib.be/en